Mitoquinone is a synthetic quinone derivative currently under investigation as an anticancer agent that acts by generating reactive oxygen species to trigger apoptosis in tumor cells. As a targeted compound… Read more
Mitoquinone is a synthetic quinone derivative currently under investigation as an anticancer agent that acts by generating reactive oxygen species to trigger apoptosis in tumor cells. As a targeted compound being evaluated for the treatment of various solid tumors, such as ovarian cancer and glioblastoma, high-quality analytical standards are essential for its research and development. This category provides access to critical materials, including the parent compound Mitoquinone Mesylate and its stable isotope-labelled analogue, Mitoquinone-d15 Mesylate. These reference standards are indispensable for pharmaceutical laboratories conducting impurity profiling, method validation, and precise quantification. By utilizing these stable isotope-labelled compounds as internal standards in mass spectrometry, researchers can ensure the accuracy and reliability of their data during the quality control of this investigational therapeutic, supporting rigorous preclinical and clinical study requirements.